Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
6.47
-0.13 (-1.97%)
Mar 31, 2025, 10:57 AM EDT - Market open

Phathom Pharmaceuticals Statistics

Total Valuation

PHAT has a market cap or net worth of $442.40 million. The enterprise value is $708.98 million.

Market Cap 442.40M
Enterprise Value 708.98M

Important Dates

The last earnings date was Thursday, March 6, 2025, before market open.

Earnings Date Mar 6, 2025
Ex-Dividend Date n/a

Share Statistics

PHAT has 68.38 million shares outstanding. The number of shares has increased by 23.18% in one year.

Current Share Class 68.38M
Shares Outstanding 68.38M
Shares Change (YoY) +23.18%
Shares Change (QoQ) +9.93%
Owned by Insiders (%) 3.79%
Owned by Institutions (%) 70.57%
Float 55.66M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 7.55
Forward PS 2.68
PB Ratio -1.78
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 12.83
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.20

Current Ratio 4.20
Quick Ratio 3.92
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -3.85

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -43.78%
Return on Invested Capital (ROIC) -51.42%
Return on Capital Employed (ROCE) -94.83%
Revenue Per Employee $129,396
Profits Per Employee -$782,965
Employee Count 427
Asset Turnover 0.14
Inventory Turnover 3.61

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -40.27% in the last 52 weeks. The beta is 0.64, so PHAT's price volatility has been lower than the market average.

Beta (5Y) 0.64
52-Week Price Change -40.27%
50-Day Moving Average 5.87
200-Day Moving Average 10.94
Relative Strength Index (RSI) 59.60
Average Volume (20 Days) 1,378,051

Short Selling Information

The latest short interest is 14.36 million, so 21.00% of the outstanding shares have been sold short.

Short Interest 14.36M
Short Previous Month 13.92M
Short % of Shares Out 21.00%
Short % of Float 25.79%
Short Ratio (days to cover) 11.78

Income Statement

In the last 12 months, PHAT had revenue of $55.25 million and -$334.33 million in losses. Loss per share was -$5.29.

Revenue 55.25M
Gross Profit 47.28M
Operating Income -277.47M
Pretax Income -297.11M
Net Income -334.33M
EBITDA -276.67M
EBIT -277.47M
Loss Per Share -$5.29
Full Income Statement

Balance Sheet

The company has $297.26 million in cash and $554.95 million in debt, giving a net cash position of -$257.69 million or -$3.77 per share.

Cash & Cash Equivalents 297.26M
Total Debt 554.95M
Net Cash -257.69M
Net Cash Per Share -$3.77
Equity (Book Value) -253.58M
Book Value Per Share -3.70
Working Capital 274.41M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$266.77 million and capital expenditures -$135,000, giving a free cash flow of -$266.91 million.

Operating Cash Flow -266.77M
Capital Expenditures -135,000
Free Cash Flow -266.91M
FCF Per Share -$3.90
Full Cash Flow Statement

Margins

Gross Margin 85.57%
Operating Margin -502.18%
Pretax Margin -605.09%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PHAT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -23.18%
Shareholder Yield n/a
Earnings Yield -74.08%
FCF Yield -59.14%

Analyst Forecast

The average price target for PHAT is $23.00, which is 255.49% higher than the current price. The consensus rating is "Strong Buy".

Price Target $23.00
Price Target Difference 255.49%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 78.70%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

PHAT has an Altman Z-Score of -5.4 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -5.4
Piotroski F-Score 3